Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series
- Friday, February 18, 2022, 7:15
- PR Newswire
- Add a comment
REDWOOD CITY, Calif., Feb. 18, 2022 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro’s Chairman, CEO and President, Rod…